Doctor profile · Federal record
Dr. Benjamin Dubin, M.D.
Specialist (CMS: Dermatology) · Gurnee, IL
- NPI 1356495030
- Accepts Medicare
- MIPS 79.5 / 100 · 2023
- 37 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
103 S Greenleaf St, Suite J
Gurnee, IL 600313380
(847) 662-8201
fax (847) 662-8215
Credentials & registration
- NPI registered
- January 2007 — 19 yrs on file
- Profile last updated
- February 12, 2008
- Year of graduation
- 1989 — 37 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- Medicaid
- IL #0360399611
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1356495030. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,774
Distinct HCPCS
10
Medicare allowed
$167,827
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
96910 |
Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 327 | 13 | $126 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 325 | 74 | $7 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 192 | 148 | $135 | |
17000 |
Destruction of precancer skin growth, 1 growth | 179 | 115 | $63 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 171 | 20 | $1 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 151 | 131 | $95 | |
17110 |
Destruction of skin growth, 1-14 growths | 104 | 78 | $122 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 74 | 74 | $174 | |
11102 |
Biopsy of related skin growth, first growth | 73 | 65 | $101 | |
J7308 |
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 61 | 24 | $385 |
In context: peer comparison
Among 5 peers in Gurnee Specialist, average services per provider: 197. This provider delivers 9.0× the peer median.Open Payments
Industry payments received
All-time total
$2,572
Transactions
101
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 16 | $363.27 | |
| Lilly USA, LLC | 17 | $338.77 | |
| Genzyme Corporation | 11 | $334.27 | |
| Ucb, INC. | 8 | $285.80 | |
| Regeneron Healthcare Solutions, INC. | 10 | $267.71 | |
| E.R. Squibb & Sons, L.L.C. | 8 | $242.43 | |
| Sun Pharmaceutical Industries INC. | 5 | $114.66 | |
| Novartis Pharmaceuticals Corporation | 4 | $86.87 | |
| Mayne Pharma Commercial LLC | 4 | $85.05 | |
| Arcutis Biotherapeutics, INC. | 4 | $82.06 | |
| Sandoz INC. | 3 | $77.36 | |
| Verrica Pharmaceuticals INC. | 3 | $72.35 | |
| Incyte Corporation | 2 | $46.68 | |
| Dermavant Sciences, INC. | 2 | $41.68 | |
| Strata Skin Sciences, INC. | 4 | $41.21 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
180
Patients
86
Total drug cost
$156,222
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 61 | 48 | $806 |
| Clobetasol Propionate | Generic | 30 | 23 | $1,442 |
| Metronidazole | Generic | 22 | 15 | $1,523 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 16 | 0 | $817 |
| Calcipotriene | Generic | 15 | 0 | $6,560 |
| Econazole Nitrate | Generic | 13 | 0 | $836 |
| Humira(Cf) Pen (Adalimumab) | Brand | 12 | 0 | $89,717 |
| Otezla (Apremilast) | Brand | 11 | 0 | $54,521 |
Frequently asked questions
What is Dr. Benjamin Dubin's medical specialty?
Dr. Benjamin Dubin practices Specialist in Gurnee, IL.
Where does Dr. Benjamin Dubin practice?
Dr. Benjamin Dubin practices at 103 S Greenleaf St, Gurnee, IL 600313380. Office phone: 8476628201.
What is Dr. Benjamin Dubin's NPI?
Dr. Benjamin Dubin's National Provider Identifier (NPI) is 1356495030, issued by NPPES.
Does Dr. Benjamin Dubin accept Medicare assignment?
Yes. Dr. Benjamin Dubin accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Benjamin Dubin commonly perform?
Top Medicare-reported procedures in 2023: Therapy procedure using ultraviolet radiation with tar or petroleum jelly application (HCPCS 96910); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.